Investor Relations

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Theravance, Inc. Investor Relations SEC Filings section.


SEC Filings
Date Filed Filing Description View
Apr 11, 2017 DEF 14A definitive proxy statement HTML PDF XLS Add to Briefcase
Mar 8, 2017 4 haumann, brett k HTML PDF XLS Add to Briefcase
Mar 7, 2017 4 shafer, bradford j HTML PDF XLS Add to Briefcase
Mar 3, 2017 S-8 registration statement HTML PDF XLS Add to Briefcase
Mar 1, 2017 10-K annual report HTML PDF XLS XBRL Add to Briefcase
Feb 27, 2017 8-K current report HTML PDF XLS Add to Briefcase
Feb 22, 2017 4 winningham, rick e HTML PDF XLS Add to Briefcase
Feb 22, 2017 4 pitzer, kenneth r HTML PDF XLS Add to Briefcase
Feb 22, 2017 4 worboys, philip d HTML PDF XLS Add to Briefcase
Feb 22, 2017 4 shafer, bradford j HTML PDF XLS Add to Briefcase
1
... NextLast
Add to Briefcase = add PDF file to Briefcase
By clicking on the link below, you will leave www.theravance.com.
CancelContinue
Form content here please :)